YPrime eCOA Platform

YPrime provides eCOA, IRT and eConsent technology for clinical trials, serving sponsors and CROs. Its press release is datelined Malvern, Pennsylvania and says it has nearly two decades of experience; the website does not state a founding year.

The eCOA platform covers ePRO, eClinRO, eObsRO and ePerfO with a pre-validated build, support for BYOD or provisioned devices, investigator sign-off, audit trails and real-time dashboards. Localization combines AI-drafted translation with specialist review across 250+ languages and 100+ countries.

• eCOA instruments: ePRO, eClinRO, eObsRO and ePerfO in one platform.
• Participant Hub: a For You page with visit schedules, study education and task priorities.
• Device flexibility: BYOD, provisioned devices or both.
• Reporting: real-time dashboards, trend analysis and alerts.
• Localization: 250+ languages with AI-drafted translation and specialist review.
• Integrations: wearables, glucometers, sensors, EDC data workflows, IRT and eConsent.

Global sponsors adding Vietnamese sites could use localized eCOA with BYOD to collect patient-reported outcomes. CROs in the region could run pediatric or chronic disease studies with at-home questionnaires.

Shortens build, translation and validation timelines through a pre-validated platform. Handles protocol amendments quickly. Supports mixed device strategies. Integrates eCOA with IRT and eConsent. Participant Hub aims to ease burden and support retention.

Sponsors are moving eCOA to flexible, patient-centric designs with AI-assisted localization. As more global studies add Asian sites, multilingual instruments for languages such as Vietnamese become a requirement for site activation.

Recognitions listed on the site: Everest Group eCOA PEAK Matrix 2025 (Leader), Clinical Trials Arena Excellence Awards 2025, EcoVadis Silver (January 2026). Claims about 1,000 studies and 55,000+ sites.